Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/193123
Title: | TRAIL receptors promote constitutive and inducible IL-8 secretion in non-small cell lung carcinoma |
Author: | Favaro, Francesca Luciano Mateo, Fedra Moreno Caceres, Joaquim Hernández Madrigal, Miguel Both, Demi Montironi, Chiara Püschel, Franziska Nadal, Ernest Eldering, Eric Muñoz Pinedo, Cristina |
Keywords: | Càncer de pulmó Apoptosi Interleucines Lung cancer Apoptosis Interleukins |
Issue Date: | 15-Dec-2022 |
Publisher: | Springer Science and Business Media LLC |
Abstract: | Interleukin-8 (IL-8/CXCL8) is a pro-angiogenic and pro-inflammatory chemokine that plays a role in cancer development. Non-small cell lung carcinoma (NSCLC) produces high amounts of IL-8, which is associated with poor prognosis and resistance to chemo-radio and immunotherapy. However, the signaling pathways that lead to IL-8 production in NSCLC are unresolved. Here, we show that expression and release of IL-8 are regulated autonomously by TRAIL death receptors in several squamous and adenocarcinoma NSCLC cell lines. NSCLC constitutively secrete IL-8, which could be further enhanced by glucose withdrawal or by treatment with TRAIL or TNF alpha. In A549 cells, constitutive and inducible IL-8 production was dependent on NF-kappa B and MEK/ERK MAP Kinases. DR4 and DR5, known regulators of these signaling pathways, participated in constitutive and glucose deprivation-induced IL-8 secretion. These receptors were mainly located intracellularly. While DR4 signaled through the NF-kappa B pathway, DR4 and DR5 both regulated the ERK-MAPK and Akt pathways. FADD, caspase-8, RIPK1, and TRADD also regulated IL-8. Analysis of mRNA expression data from patients indicated that IL-8 transcripts correlated with TRAIL, DR4, and DR5 expression levels. Furthermore, TRAIL receptor expression levels also correlated with markers of angiogenesis and neutrophil infiltration in lung squamous carcinoma and adenocarcinoma. Collectively, these data suggest that TRAIL receptor signaling contributes to a pro-tumorigenic inflammatory signature associated with NSCLC. |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/s41419-022-05495-0 |
It is part of: | Cell Death & Disease, 2022, vol. 13, num. 12, p.1046 |
URI: | http://hdl.handle.net/2445/193123 |
Related resource: | https://doi.org/10.1038/s41419-022-05495-0 |
ISSN: | 2041-4889 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s41419-022-05495-0.pdf | 3.94 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License